Health Catalyst Inc (HCAT)
8.31
-0.08
(-0.95%)
USD |
NASDAQ |
Sep 27, 16:00
8.34
+0.03
(+0.36%)
Pre-Market: 20:00
Health Catalyst Research and Development Expense (TTM): 66.71M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 66.71M |
| March 31, 2024 | 70.42M |
| December 31, 2023 | 72.63M |
| September 30, 2023 | 71.95M |
| June 30, 2023 | 75.06M |
| March 31, 2023 | 75.61M |
| December 31, 2022 | 75.68M |
| September 30, 2022 | 73.54M |
| June 30, 2022 | 69.16M |
| March 31, 2022 | 65.54M |
| December 31, 2021 | 62.73M |
| September 30, 2021 | 60.23M |
| Date | Value |
|---|---|
| June 30, 2021 | 57.24M |
| March 31, 2021 | 54.77M |
| December 31, 2020 | 53.52M |
| September 30, 2020 | 51.58M |
| June 30, 2020 | 51.67M |
| March 31, 2020 | 49.32M |
| December 31, 2019 | 46.25M |
| September 30, 2019 | 43.77M |
| June 30, 2019 | 41.13M |
| March 31, 2019 | 39.91M |
| December 31, 2018 | 38.59M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
43.77M
Minimum
Sep 2019
75.68M
Maximum
Dec 2022
62.37M
Average
64.13M
Median